PAUL B. ROTHMAN, M.D.

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Merck & Co., Inc.

Filing Date Source Excerpt
2017-04-10 Dean of Medical Faculty and Vice President for Medicine, The Johns Hopkins University
2018-04-09 In deciding to nominate Dr. Rothman, the Board considered his extensive expertise in patient care, science and medicine relevant to the pharmaceutical industry.
2019-04-08 Dr. Rothman has extensive expertise in patient care, science and medicine relevant to the pharmaceutical industry.
2020-04-06 Dr. Rothman has extensive expertise in patient care, science and medicine relevant to the pharmaceutical industry.
2021-04-05 Dr. Rothman has extensive expertise in patient care, science and medicine relevant to the pharmaceutical industry.
2022-04-04 Dr. Rothman has extensive expertise in patient care, science and medicine relevant to the pharmaceutical industry.

Data sourced from SEC filings. Last updated: 2025-07-01